Craig C. Hofmeister, MD, MPH, is Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.

Leslie L. Popplewell, M.D., is the medical director, Hematology and Blood and Marrow Transplant, at City of Hope® Cancer Center Atlanta. She also serves as the principal investigator for a number of clinical trials examining new lymphoma therapies including CAR T cells and phase 1 and first in human trials. In addition, she is working on advanced transplant techniques for patients whose lymphoma has recurred. Dr. Popplewell received her medical degree from the University of Louisville School of Medicine. She joined City of Hope in 1998 following a fellowship at the renowned Memorial Sloan Kettering Cancer Center in New York City.